Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

09. June 2018

Centers for Medicare & Medicaid Services publish preliminary rate of $192 for Epigenomics’ colorectal cancer screening test Epi proColon®

Read more

30. May 2018

Epigenomics AG: American Cancer Society published its updated colorectal cancer screening guidelines

Read more

17. April 2018

Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG

Read more
...

Press releases

22. October 2018

Centers for Medicare & Medicaid Services publish final rate of $192 for Epigenomics’ colorectal cancer screening blood test Epi proColon®

Read more

08. October 2018

Epigenomics AG: Capital increase through rights issue with subscription rights of existing shareholders

Read more

02. October 2018

Epigenomics AG: U.S. Congress supports CMS coverage of colorectal cancer screening blood tests

Read more
...

Archive

News Categories

Media Contact

Peter Vogt
Vice President
Corporate Communications
& Investor Relations
T +49 30 24345-386
F +49 30 24345-555
pr@epigenomics.com